Financials

  • Market Capitalization 182.74 M
  • Employee 61
  • Founded 1996
  • CEO N/A
  • Website www.acumenpharm.com
  • Headquarter Delaware, United States
  • FIGI BBG0058YJ317
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.05
Fiyat/satışlar oranı
638.93

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3658
NKTX
Nkarta, Inc. - Common Stock
2.65 USD-5.02%-19.70%-11.37%+40.21%189.60 M USD
3663
QSI
Quantum-Si Incorporated - Class A Common Stock
0.86 USD-1.15%-6.52%-14.00%-51.69%187.27 M USD
3669
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.31 USD-3.75%-1.70%+12.14%-20.89%186.12 M USD
3683
TNYA
Tenaya Therapeutics, Inc. - Common Stock
0.86 USD+2.38%0.00%+16.22%+19.44%186.62 M USD

Haberler